Allergy and Immunology, Clinical & Laboratory Immunology · Tulsa, OK
NPI
1447299151
Since 2006
Specialty
Allergy and Immunology, Clinical & Laboratory Immunology
Code 207KI0005X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9311 S Mingo Rd
Tulsa, OK, 74133
Phone (918) 307-1613
Medicare paid, 2024
$695K
37,683 services
Medicare patients, 2024
712
Average age 72
Drug cost, 2024
$1.1M
1,149 prescriptions
Company payments, 2025
$203
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn C Brown was code J1569 (injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg), 4,522 times for 19 patients. In total Kathryn C Brown billed 37,683 services in 51 codes, and Medicare paid $695K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 4,522 | 19 | $34.62 | $157K |
| J2357 Injection, omalizumab, 5 mg | Office | 4,515 | 25 | $29.72 | $134K |
| 95004 Test - Miscellaneous | Office | 2,851 | 56 | $2.53 | $7,220 |
| 95165 Treatment - Miscellaneous | Office | 2,247 | 213 | $9.27 | $21K |
| 95117 Treatment - Miscellaneous | Office | 1,400 | 319 | $7.59 | $11K |
| 95044 Test - Miscellaneous | Office | 1,195 | 19 | $3.37 | $4,029 |
| 95024 Test - Miscellaneous | Office | 785 | 42 | $5.58 | $4,379 |
| 95115 Treatment - Miscellaneous | Office | 390 | 82 | $6.55 | $2,556 |
| 96372 Injection Administration | Office | 205 | 44 | $10.08 | $2,065 |
| 99213 Office E&M - Established | Office | 193 | 167 | $57.79 | $11K |
| 96370 Intravenous Infusion, Hydration | Office | 131 | 14 | $11.62 | $1,522 |
| 96366 Intravenous Infusion, Hydration | Office | 113 | 12 | $14.63 | $1,653 |
| 96369 Intravenous Infusion, Hydration | Office | 78 | 14 | $98.82 | $7,708 |
| 99203 Office E&M - New | Office | 59 | 59 | $70.74 | $4,174 |
| 95012 Pulmonary | Office | 54 | 49 | $11.73 | $634 |
By year: 2022 $627K for 24,489 services; 2023 $721K for 32,548 services; 2024 $695K for 37,683 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn C Brown prescribed most often to Medicare patients was Montelukast Sodium, with 197 prescriptions and refills. In total Kathryn C Brown wrote 1,149 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 197 | 508 | 59 | $5,087 |
| Fluticasone Propionate Generic | 106 | 236 | 43 | $2,495 |
| Ipratropium Bromide Generic | 96 | 154 | 36 | $2,446 |
| Azelastine Hcl Generic | 90 | 181 | 41 | $3,340 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 58 | 59 | 37 | $1,124 |
| Breo Ellipta Fluticasone/Vilanterol | 53 | 75 | 12 | $29K |
| Advair Hfa Fluticasone Propion/Salmeterol | 49 | 63 | Under 11 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 47 | 80 | 14 | $51K |
| Famotidine Generic | 46 | 88 | 11 | $1,093 |
| Prednisone Generic | 37 | 45 | 32 | $80.89 |
| Epinephrine Generic | 35 | 36 | 30 | $5,513 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 35 | 53 | 12 | $4,022 |
| Xolair Omalizumab | 24 | 24 | Under 11 | $85K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 16 | 16 | 14 | $220 |
| Symbicort Budesonide/Formoterol Fumarate | 15 | 31 | Under 11 | $6,753 |
Brand drugs: 389 claims; generic drugs: 760 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn C Brown $203 ($203 in general payments such as food, travel and fees) from 8 companies. The largest payer was CSL Behring with $59.59.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 3 | $59.59 |
| Genzyme Corporation SNY | 1 | $29.26 |
| Pfizer Inc. PFE | 1 | $27.6 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $25.33 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $17.12 |
| GlaxoSmithKline, LLC. GSK | 1 | $16.6 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $14.29 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $13.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.